Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group
Khaled Elsayad, Emmanuella Guenova, Chalid Assaf, Jan P. Nicolay, Franz Trautinger, Rudolf Stadler, Cora Waldstein, Tom Boterberg, P. Meijnders, Youlia Kirova, Gábor Dobos, Víctor Duque‐Santana, Elena Riggenbach, Wael El-Sheshtawy, Anne G.H. Niezink, Evangelia Papadavid, Julia Scarisbrick, Maarten H. Vermeer, Karen J. Neelis, M. Bagot, Maxime Battistella, Pietro Quaglino, Robert Knobler, Werner Kempf, Ahmed Maklad, Sebastian Adeberg, Vassilis Kouloulias, Gabriele Simontacchi, Stefanie Corradini, Laila König, Hans Theodor Eich, Richard Cowan, Dora Correia
Abstract
The number of primary cutaneous lymphoma patients receiving low-dose radiotherapy is increasing, though controlled clinical trials defining the standard radiation dose for each specific entity have not yet been completed. Radiation oncologists are left with making highly individualized decisions that would be better enriched by additional clinical evidence. In this expert opinion, we aim to provide a clear recommendation to improve the current practice of radiation oncology. In addition, existing literature has been reviewed to develop recommendations for all types of primary cutaneous lymphoma. A prospective trial is urgently needed to identify the factors influencing patient outcomes following different radiation doses.